Iacomino, N.; Vanoli, F.; Frangiamore, R.; Ballardini, M.; Scandiffio, L.; Bortone, F.; Andreetta, F.; Baggi, F.; Bernasconi, P.; Antozzi, C.;
et al. Complement Activation Profile in Myasthenia Gravis Patients: Perspectives for Tailoring Anti-Complement Therapy. Biomedicines 2022, 10, 1360.
https://doi.org/10.3390/biomedicines10061360
AMA Style
Iacomino N, Vanoli F, Frangiamore R, Ballardini M, Scandiffio L, Bortone F, Andreetta F, Baggi F, Bernasconi P, Antozzi C,
et al. Complement Activation Profile in Myasthenia Gravis Patients: Perspectives for Tailoring Anti-Complement Therapy. Biomedicines. 2022; 10(6):1360.
https://doi.org/10.3390/biomedicines10061360
Chicago/Turabian Style
Iacomino, Nicola, Fiammetta Vanoli, Rita Frangiamore, Marta Ballardini, Letizia Scandiffio, Federica Bortone, Francesca Andreetta, Fulvio Baggi, Pia Bernasconi, Carlo Antozzi,
and et al. 2022. "Complement Activation Profile in Myasthenia Gravis Patients: Perspectives for Tailoring Anti-Complement Therapy" Biomedicines 10, no. 6: 1360.
https://doi.org/10.3390/biomedicines10061360
APA Style
Iacomino, N., Vanoli, F., Frangiamore, R., Ballardini, M., Scandiffio, L., Bortone, F., Andreetta, F., Baggi, F., Bernasconi, P., Antozzi, C., Cavalcante, P., & Mantegazza, R.
(2022). Complement Activation Profile in Myasthenia Gravis Patients: Perspectives for Tailoring Anti-Complement Therapy. Biomedicines, 10(6), 1360.
https://doi.org/10.3390/biomedicines10061360